Jennison Global Healthcare Master Fund, Ltd. - Net Worth and Insider Trading
Jennison Global Healthcare Master Fund, Ltd. Net Worth
The estimated net worth of Jennison Global Healthcare Master Fund, Ltd. is at least $424,709 dollars as of 2024-09-20. Jennison Global Healthcare Master Fund, Ltd. is the 10% Owner of Alpine Immune Sciences Inc and owns about 6,537 shares of Alpine Immune Sciences Inc (ALPN) stock worth over $424,709. Details can be seen in Jennison Global Healthcare Master Fund, Ltd.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jennison Global Healthcare Master Fund, Ltd. has not made any transactions after 2015-06-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jennison Global Healthcare Master Fund, Ltd.
Jennison Global Healthcare Master Fund, Ltd. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jennison Global Healthcare Master Fund, Ltd. owns 1 companies in total, including Alpine Immune Sciences Inc (ALPN) .
Insider Ownership Summary of Jennison Global Healthcare Master Fund, Ltd.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALPN | Alpine Immune Sciences Inc | 2015-06-17 | 10 percent owner |
Jennison Global Healthcare Master Fund, Ltd. Latest Holdings Summary
Jennison Global Healthcare Master Fund, Ltd. currently owns a total of 1 stock. Jennison Global Healthcare Master Fund, Ltd. owns 6,537 shares of Alpine Immune Sciences Inc (ALPN) as of June 17, 2015, with a value of $424,709.
Latest Holdings of Jennison Global Healthcare Master Fund, Ltd.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALPN | Alpine Immune Sciences Inc | 2015-06-17 | 6,537 | 64.97 | 424,709 |
Holding Weightings of Jennison Global Healthcare Master Fund, Ltd.
Jennison Global Healthcare Master Fund, Ltd. Form 4 Trading Tracker
According to the SEC Form 4 filings, Jennison Global Healthcare Master Fund, Ltd. has made a total of 0 transactions in Alpine Immune Sciences Inc (ALPN) over the past 5 years. The most-recent trade in Alpine Immune Sciences Inc is the acquisition of 6,537 shares on June 17, 2015, which cost Jennison Global Healthcare Master Fund, Ltd. around $366,086.
Insider Trading History of Jennison Global Healthcare Master Fund, Ltd.
- 1
Jennison Global Healthcare Master Fund, Ltd. Trading Performance
GuruFocus tracks the stock performance after each of Jennison Global Healthcare Master Fund, Ltd.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jennison Global Healthcare Master Fund, Ltd. is 20.71%. GuruFocus also compares Jennison Global Healthcare Master Fund, Ltd.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Jennison Global Healthcare Master Fund, Ltd. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jennison Global Healthcare Master Fund, Ltd.'s insider trading performs compared to the benchmark.
Performance of Jennison Global Healthcare Master Fund, Ltd.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 27.41 | | | | | |
| Relative Return to S&P 500(%) | 26.16 | | | | | |
Jennison Global Healthcare Master Fund, Ltd. Ownership Network
Jennison Global Healthcare Master Fund, Ltd. Owned Company Details
What does Alpine Immune Sciences Inc do?
Who are the key executives at Alpine Immune Sciences Inc?
Jennison Global Healthcare Master Fund, Ltd. is the 10 percent owner of Alpine Immune Sciences Inc. Other key executives at Alpine Immune Sciences Inc include Senior VP and CFO James Paul Rickey , director & Executive Chairman and CEO Mitchell Gold , and director & 10 percent owner Xiangmin Cui .
Alpine Immune Sciences Inc (ALPN) Insider Trades Summary
Over the past 18 months, Jennison Global Healthcare Master Fund, Ltd. made no insider transaction in Alpine Immune Sciences Inc (ALPN). Other recent insider transactions involving Alpine Immune Sciences Inc (ALPN) include a net sale of 281,514 shares made by James Paul Rickey , a net sale of 213,302 shares made by Mitchell Gold , and a net sale of 1,546,347 shares made by Peter A. Thompson .
In summary, during the past 3 months, insiders sold 0 shares of Alpine Immune Sciences Inc (ALPN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,587,529 shares of Alpine Immune Sciences Inc (ALPN) were sold and 750,000 shares were bought by its insiders, resulting in a net sale of 2,837,529 shares.
Alpine Immune Sciences Inc (ALPN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alpine Immune Sciences Inc Insider Transactions
Jennison Global Healthcare Master Fund, Ltd. Mailing Address
Above is the net worth, insider trading, and ownership report for Jennison Global Healthcare Master Fund, Ltd.. You might contact Jennison Global Healthcare Master Fund, Ltd. via mailing address: C/o Jennison Associates Llc, 466 Lexington Avenue, New York Ny 10017.
Discussions on Jennison Global Healthcare Master Fund, Ltd.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
